MARKET

BMRA

BMRA

Biomerica Inc
NASDAQ
2.637
+0.037
+1.43%
Opening 15:19 01/06 EST
OPEN
2.530
PREV CLOSE
2.600
HIGH
2.690
LOW
2.530
VOLUME
30.25K
TURNOVER
--
52 WEEK HIGH
10.16
52 WEEK LOW
2.110
MARKET CAP
7.77M
P/E (TTM)
-1.6203
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BMRA last week (1229-0102)?
Weekly Report · 1d ago
Weekly Report: what happened at BMRA last week (1222-1226)?
Weekly Report · 12/29/2025 09:08
Biomerica announces CMS Medicare payment rate of $300 for IBS test
TipRanks · 12/23/2025 13:25
Biomerica Says CMS Issues Final Pricing Determination For inFoods IBS Test, Establishing National Medicare Payment Rate Of $300 Under CLFS
Benzinga · 12/23/2025 13:21
BIOMERICA INC - $300 RATE APPLIES TO MEDICARE CLAIMS FROM JANUARY 2026
Reuters · 12/23/2025 13:19
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test
Barchart · 12/23/2025 07:19
Two new option listings and eighteen option delistings on December 22nd
TipRanks · 12/22/2025 13:35
Weekly Report: what happened at BMRA last week (1215-1219)?
Weekly Report · 12/22/2025 09:08
More
About BMRA
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.

Webull offers Biomerica Inc stock information, including NASDAQ: BMRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BMRA stock methods without spending real money on the virtual paper trading platform.